Economic consequences of near-patient test results: The case of tests for the Helicobacter Pylori bacterium in dyspepsia

European Journal of Health Economics

Volumn 9, Issue 3, 2008, Pages 221-228

  Fauli, Siri ^a   Thue, Geir ^b  

^a Research Institute of the Norwegian Medical Association   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Cost effectiveness; General practice; Laboratory tests; Probabilistic sensitivity analysis

Indexed keywords

ARTICLE; BACTERIUM DETECTION; BLOOD SAMPLING; CLINICAL LABORATORY; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DIAGNOSTIC ACCURACY; DYSPEPSIA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GASTROINTESTINAL ENDOSCOPY; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH ECONOMICS; HELICOBACTER PYLORI; HOSPITAL; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MEDICAL DECISION MAKING; MODEL; NONHUMAN; NORWAY; PEPTIC ULCER; PRIORITY JOURNAL; PROBABILITY; QUESTIONNAIRE; RESOURCE MANAGEMENT;

ADULT; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MODELS, ECONOMIC; NORWAY; POINT-OF-CARE SYSTEMS; PROBABILITY; SENSITIVITY AND SPECIFICITY;

EID: 46949086226     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-007-0064-3     Document Type: Article

References (37)

1. Haug, T.T.: Functional dyspepsia-a psychosomatic disease. Tidsskr. Nor. Lægeforen. 122, 1218-1222 (2002)
2. Kristensen, P., Sandbakken, P., Johannessen, T., Løge, I., Hafstad, P.E., Petersen, H., Fjøsne, U., Kleveland, P.M.: Fordøyelsessykdommer I almenpraksis. Tidsskr. Nor. Lægeforen. nr 11 105, 728-731 (1985)
3. Logan, R., Delaney, B.: ABC of the upper gastrointestinal tract. Implications of dyspepsia for the NHS. BMJ 323, 675-677 (2001)
4. Petersen, H.: Legemiddelbehandling av funksjonell dyspepsi. (medicinal treatment of functional dyspepsia). Tidsskr. Nor. Lægeforen. nr 24 121, 2839-2840 (2001)
5. Atherton, J.C., Blaser, M.J., 19.10.99. Helicobacter infections. http://www.harrisononline.com/server-java/Arknoid/harrisons/1096-7133/Ch156/ Page1.htm
6. Friedman, L.S., 19.10.99. Helicobacter pylori: What's new. Editorial related to Chapter 284: Peptic Ulcer and related disorders. http://www. harrisononline.com/server-java/Arknoid/harrisons/1096-7133/.../edl1426.htm
7. Asante, A.M., Mendall, A.M., Finlayson, C., Ballam, L., Northfield, T.: Screening dyspeptic patients for Helicobacter pylori prior to endoscopy: laboratory or near-patient testing? Eur. J. Gastroenterol. Hepatol. 10(10), 843-846 (1998)
8. Duggan, A.E., Elliott, C., Logan, R.F.A.: Testing for Helicobacter pylori infection: validation and diagnostic yield of a near patient test in primary care. BMJ 319, 1236-1239 (1999)
9. Fauli, S., Thue, G.: Decision-making in general practice: the importance of laboratory analyses when choosing medical actions. University of Oslo. Health research programme. Working paper 12 (2005)
10. Hunink M., Glasziou P., Siegel J., Weeks J., Pliskin J., Elstein A., Weinstein M.: Decision making in health and medicine. Cambridge University Press, Cambridge (2004)
11. Gold, M.R., Siegel, J.E., Russell, L.B., et al Cost-effectiveness in health and medicine. Oxford University Press, New York (1996)
12. Ford, A.C., Qume, M., Moayyedi, P., et al Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology 128, 138-144 (2005)
13. Lassen, A.T., Hallas, J., Schaffalitzky de Muckadell, O.B.: Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 years follow up of a randomised trial. Gut 53, 1758-1763 (2004)
14. Ofman, J.J., Etchason, J., Fullerton, S., Kahn, K., Soli, A.: Management strategies for helicobacter pylori-seropositive patients with dyspepsia. Ann. Intern. Med. 126(4), 280-291 (1997)
15. Briggs, A.H., Sculpher, M.J., Logan, R.P.H., Aldous, J., Ramsay, M.E., Baron, J.H.: Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ 312, 1321-1325 (1996)
16. Hunskår S, (ed). Allmennmedisin-Klinisk arbeid (Norwegian textbook of general practice). Ad Notam Gyldendal (1997)
17. Petersen, H., Johannessen, T.: Helicobacter pylori-vet vi hva vi gjør (Helicobacter pylori-do we know what we are doing?). Tidsskr. Nor. Laegeforen. 118(10), 1540-1541 (1998)
18. TreeAge Software Inc. Williamstown, USA
19. Jones, R., Britten, N., Culpepper, L., Gass, D.A., Grol, R., Mant, D., Silagy, C.: Oxford textbook of primary medical care. Oxford University Press, New York (2003)
20. Laheij, R.J.F., Jansen, J.B.M., Van De Lisdonk, E.H., Severens, J.L., Verbeek, A.L.M.: Review article: symptoms improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. Aliment. Pharmacol. Ther. 10, 843-850 (1996)
21. El-Seraq, H.B., Talley, N.J.: Systematic review: the prevalence and clinical course of functional dyspepsia. Aliment. Pharmacol. Ther. 19(6), 643-654 (2004)
22. Norwegian Pharmaceutical Product Compendium: Felleskatalogen AS, Oslo (1999)
23. Imperiale, T.F., Speroff, T., Randall, D.C., McCullough, A.J.: A cost analysis of alternative treatments for duodenal ulcer. Ann. Intern. Med. 123(9), 865-672 (1995)
24. Hopkins, E.J., Girardi, L.S., Turney, E.A.: Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 110, 1244-1252 (1996)
25. Hem, K.G: Økonomiske konsekvenser av sykefravær. (Economic consequences of sick leave) STFT78 A00508. SINTEF Unimed (2000)
26. National Insurance Administration. Fixed Fee schedules for 1999
27. Stangeby, I., Haukeland, J.V., Skogli, A.: Reisevaner i Norge 1998. (Travelling customs in Norway 1998) TØI report 418/1999, Oslo (1999)
28. Norwegian drug and therapeutic formulary for health personnel 2001. Foreningen for utgivelse av Norsk legemiddelhåndbok. PDC Tangen- Aurskog (2001)
29. The Norwegian Association of Proprietor Pharmacies
30. Spiegelhalter, D.J., Abrams, K.R., Myles, J.P.: Bayesian approaches to clinical trials and health-care evaluation. Wiley, England (2004)
31. Jones, T.V., Gerrity, M.S., Earp, J.: Written case simulations: do they predict physicians' behaviour? J. Clin. Epidemiol. 43, 805-815 (1990)
32. Kuyvenhoven, M.M., Jacobs, H.M., Touw-Otten, F.W.M.M, Van Es, J.C.: Written simulation of patient-doctor encounters, 1: research instrument for registration of the performance of general practitioners. Fam. Pract. 1, 14-19 (1983)
33. Peabody, J.W., Luck, J., Glassman, P., Dresselhaus, T.R., Lee, M.: Comparison of vignettes, standardized patients and chart abstraction. JAMA 283, 1715-1722 (2000)
34. Jacob-Tacken, K.H.M., Koopmanschap, M.A., Meerding, W.J., Severens, J.L: Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes
35. Severens, J.L., Laheij, R.H.F., Jansen, J.B.M.J., van de Lisdonk, E.H., Verbeek, A.L.M.: Estimating the cost of lost production in dyspepsia. Aliment. Pharmacol. Ther. 12, 919-923 (1998)
36. Koopmanschap, M.A., Rutten, F.F.H., van Inevald B.M., Roijen, L.V.: The friction cost method for measuring indirect costs of disease. J. Health Econ. 15, 171-189 (1995)
37. Fauli, S., Thue, G.: Decision making in general practice: the availability and use of a specific laboratory analysis. Int. J. Technol. Assess. Health Care 21, 3 (2005)